Literature DB >> 34508599

How Vital Are Patient-Reported Outcomes?

Steven S Chang1, Benjamin Movsas2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34508599      PMCID： PMC8902334          DOI： 10.1093/jnci/djab178

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  10 in total

1.  PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events.

Authors:  Benjamin Movsas
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

2.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.

Authors:  Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag
Journal:  JAMA       Date:  2017-07-11       Impact factor: 56.272

3.  Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer.

Authors:  Fabrice Denis; Ethan Basch; Anne-Lise Septans; Jaafar Bennouna; Thierry Urban; Amylou C Dueck; Christophe Letellier
Journal:  JAMA       Date:  2019-01-22       Impact factor: 56.272

Review 4.  Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update.

Authors:  Mirjam A G Sprangers; Melissa S Y Thong; Meike Bartels; Andrea Barsevick; Juan Ordoñana; Qiuling Shi; Xin Shelley Wang; Pål Klepstad; Eddy A Wierenga; Jasvinder A Singh; Jeff A Sloan
Journal:  Qual Life Res       Date:  2014-03-07       Impact factor: 4.147

Review 5.  Focusing on the "Person" in Personalized Medicine: The Future of Patient-Centered Care in Radiation Oncology.

Authors:  Abigail T Berman; Seth A Rosenthal; Drew Moghanaki; Kristina D Woodhouse; Benjamin Movsas; Neha Vapiwala
Journal:  J Am Coll Radiol       Date:  2016-12       Impact factor: 5.532

6.  An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication.

Authors:  Olivier Morin; Martin Vallières; Steve Braunstein; Jorge Barrios Ginart; Taman Upadhaya; Henry C Woodruff; Alex Zwanenburg; Avishek Chatterjee; Javier E Villanueva-Meyer; Gilmer Valdes; William Chen; Julian C Hong; Sue S Yom; Timothy D Solberg; Steffen Löck; Jan Seuntjens; Catherine Park; Philippe Lambin
Journal:  Nat Cancer       Date:  2021-07-22

Review 7.  Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.

Authors:  Sofia F Garcia; David Cella; Steven B Clauser; Kathryn E Flynn; Thomas Lad; Jin-Shei Lai; Bryce B Reeve; Ashley Wilder Smith; Arthur A Stone; Kevin Weinfurt
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

8.  Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

Authors:  Benjamin Movsas; Jennifer Moughan; Linda Sarna; Corey Langer; Maria Werner-Wasik; Nicos Nicolaou; Ritsuko Komaki; Mitchell Machtay; Todd Wasserman; Deborah Watkins Bruner
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

9.  Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

Authors:  Benjamin Movsas; Chen Hu; Jeffrey Sloan; Jeffrey Bradley; Ritsuko Komaki; Gregory Masters; Vivek Kavadi; Samir Narayan; Jeff Michalski; Douglas W Johnson; Christopher Koprowski; Walter J Curran; Yolanda I Garces; Rakesh Gaur; Raymond B Wynn; John Schallenkamp; Daphna Y Gelblum; Robert M MacRae; Rebecca Paulus; Hak Choy
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

10.  Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials.

Authors:  Fabio Efficace; David Cella; Neil K Aaronson; Melanie Calvert; Francesco Cottone; Massimo Di Maio; Francesco Perrone; Francesco Sparano; Eva-Maria Gamper; Marco Vignetti; Johannes M Giesinger
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.